BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹172 Cr | ₹157 Cr | ₹193 Cr | ₹233 Cr | ₹204 Cr |
What is the latest Total Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹193 Cr |
| Mar2022 | ₹233 Cr |
| Mar2021 | ₹204 Cr |
How is Total Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹172 Cr | 9.09 | |
| Mar2024 | ₹157 Cr | -18.55 | |
| Mar2023 | ₹193 Cr | -17.09 | |
| Mar2022 | ₹233 Cr | 14.46 | |
| Mar2021 | ₹204 Cr | - | |
Compare Total Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,716.9 Cr | 1.6% | 18.8% | 123.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 1.6% |
18.8% |
123.8% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses